1. Home
  2. ABEO vs VLN Comparison

ABEO vs VLN Comparison

Compare ABEO & VLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABEO
  • VLN
  • Stock Information
  • Founded
  • ABEO 1974
  • VLN 2006
  • Country
  • ABEO United States
  • VLN Israel
  • Employees
  • ABEO N/A
  • VLN N/A
  • Industry
  • ABEO Biotechnology: Pharmaceutical Preparations
  • VLN Semiconductors
  • Sector
  • ABEO Health Care
  • VLN Technology
  • Exchange
  • ABEO Nasdaq
  • VLN Nasdaq
  • Market Cap
  • ABEO 256.9M
  • VLN 251.6M
  • IPO Year
  • ABEO 1980
  • VLN N/A
  • Fundamental
  • Price
  • ABEO $6.24
  • VLN $2.24
  • Analyst Decision
  • ABEO Strong Buy
  • VLN Strong Buy
  • Analyst Count
  • ABEO 5
  • VLN 1
  • Target Price
  • ABEO $17.80
  • VLN $4.00
  • AVG Volume (30 Days)
  • ABEO 1.7M
  • VLN 283.9K
  • Earning Date
  • ABEO 05-15-2025
  • VLN 05-07-2025
  • Dividend Yield
  • ABEO N/A
  • VLN N/A
  • EPS Growth
  • ABEO N/A
  • VLN N/A
  • EPS
  • ABEO N/A
  • VLN N/A
  • Revenue
  • ABEO N/A
  • VLN $63,128,000.00
  • Revenue This Year
  • ABEO N/A
  • VLN $26.17
  • Revenue Next Year
  • ABEO $383.07
  • VLN $16.98
  • P/E Ratio
  • ABEO N/A
  • VLN N/A
  • Revenue Growth
  • ABEO N/A
  • VLN N/A
  • 52 Week Low
  • ABEO $3.93
  • VLN $1.67
  • 52 Week High
  • ABEO $7.32
  • VLN $3.50
  • Technical
  • Relative Strength Index (RSI)
  • ABEO 56.57
  • VLN 41.52
  • Support Level
  • ABEO $5.93
  • VLN $2.26
  • Resistance Level
  • ABEO $7.17
  • VLN $2.31
  • Average True Range (ATR)
  • ABEO 0.44
  • VLN 0.14
  • MACD
  • ABEO -0.01
  • VLN -0.04
  • Stochastic Oscillator
  • ABEO 50.00
  • VLN 16.84

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

About VLN Valens Semiconductor Ltd.

Valens Semiconductor Ltd is a provider of semiconductor products, pushing the boundaries of connectivity by enabling long-reach, high-speed video, and data transmission for the audio-video and automotive industries. It operates in two segments: Cross Industry Business, which includes solutions for the non-automotive verticals, including audio-video, industrial, machine vision and medical markets, that deliver superior, plug-and-play convergence and distribution of different interfaces, through a single long-distance category cable; and Automotive segment products enable safe and resilient high-speed in-vehicle connectivity for car architectures, realizing the vision of connected and autonomous cars. The company's geographical revenue is derived from Hungary.

Share on Social Networks: